Search - tctmd.com

Displaying 121 - 131 of 131

Sort: Relevancy | Date

Presentation TCT 2012

Complications: How to Avoid, How to Treat

Presenter: Srihari Naidu

October 25, 2012

Presentation TCT 2012

Case Selection for Alcohol Septal Ablation

Presenter: Sherif Nagueh

October 25, 2012

Presentation TCT 2012

Alcohol Septal Ablation: The Procedure Step by Step

Presenter: Christopher Nielsen

October 25, 2012

Presentation TCT 2012

Tough Call During a HOCM Ablation

Presenter: Carey Kimmelstiel

October 24, 2012

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

L.A. McKeown

October 23, 2012

News Daily News

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

L.A. McKeown

October 23, 2012

Presentation

Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Presenter: Paul Sorajja

October 19, 2012

Presentation ACVS 2012

Interventional Treatment of HOCM: Overview of Techniques and Results

Presenter: Rajeev Lochan

August 03, 2012

Presentation Fellows 2012

Hypertrophic Cardiomyopathy and Alcohol Septal Ablation

Presenter: Srihari Naidu

April 22, 2012

Presentation TCT 2012

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Presenter: Paul S. Rees, Sean M. Davidson, Sian E. Harding, Perry M. Elliott, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

News Daily News

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

L.A. McKeown

May 27, 2011

Advertisement

Complications: How to Avoid, How to Treat

Case Selection for Alcohol Septal Ablation

Alcohol Septal Ablation: The Procedure Step by Step

Tough Call During a HOCM Ablation

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Interventional Treatment of HOCM: Overview of Techniques and Results

Hypertrophic Cardiomyopathy and Alcohol Septal Ablation

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content